Lifecore Biomedical GAAP EPS of -$0.06 beats by $0.04, revenue of $36.4M beats by $1.04M
Source: SeekingAlpha
2025-08-07 17:09:31 ET
More on Lifecore Biomedical
- Lifecore Biomedical: Inflecting Financials Over Next 3 Years
- Lifecore Biomedical signs new 10-year commercial manufacturing and supply agreement
Read the full article on Seeking Alpha
For further details see:
Lifecore Biomedical GAAP EPS of -$0.06 beats by $0.04, revenue of $36.4M beats by $1.04M
Lifecore Biomedical Inc.
NASDAQ: LFCR
LFCR Trading
-2.47% G/L:
$6.52 Last:
86,018 Volume:
$6.63 Open:
LFCR Latest News
March 10, 2026 04:05:00 pm
Lifecore Biomedical to Participate in 6th Annual KeyBanc Capital Markets Healthcare Virtual Forum
March 09, 2026 04:05:00 pm
Lifecore Biomedical to Report Financial Results for the Fourth Quarter and Transition Period Ended December 31, 2025, on March 16, 2026
LFCR Stock Data
$276,501,678
20,569,027
4.87%
36
N/A
Biotechnology & Life Sciences
Healthcare
US
Chaska
